| Structure | Chemical Name | CAS | MF |
|
bidentate tetraaquarhodium-pyrophosphate complex
|
107053-38-3
|
H4O11P2Rh-
|
|
9-(4-Hydroxy-3-(hydroxymethyl)-2-butenyl)adenine
|
107053-43-0
|
|
|
2,6-DI-TERT-BUTYLPYRIDINE, POLYMER-BOUND
|
107054-29-5
|
C45H69N3X2
|
|
2-IODO-3,3,3-TRIFLUOROPROPENE
|
107070-09-7
|
C3H2F3I
|
|
4-(Dimethylamino)-2-hydroxyacetophenone
|
107070-69-9
|
C10H13NO2
|
|
[3-(1H-PYRROL-1-YL)-2-THIENYL]METHANOL
|
107073-27-8
|
C9H9NOS
|
|
3-(1H-PYRROL-1-YL)-2-THIOPHENECARBALDEHYDE
|
107073-28-9
|
C9H7NOS
|
|
2(1H)-Quinoxalinone,3,4-dihydro-1,4-dimethyl-3-methylene-(9CI)
|
107073-47-2
|
C11H12N2O
|
|
rac trans-2-Phenylcyclopropanecarboxylic-d5 Acid
|
107077-95-2
|
C10H10O2
|
|
trans 2-(Phenyl-D5)-cyclopropylamine Hydrochloride
|
107077-98-5
|
C9H7D5ClN
|
|
(S)-4-vinyl-dihydrofuran-2(3H)-one
|
107080-45-5
|
C6H8O2
|
|
butropium
|
107080-63-7
|
C28H38NO4+
|
|
oxobis(phenolato)(tris(3,5-dimethyl-1-pyrazolyl)-hydroborato)molybdenum(V)
|
107081-62-9
|
C27H32BMoN6O3
|
|
Bicyclo[2.2.1]heptan-2-ol, 2-(2-cyclopenten-1-yl)-
|
107081-99-2
|
|
|
N-(3-(4-azido-3-iodophenyl)propionyl)succinimide
|
107082-23-5
|
|
|
2,6-Methanoazirino[2,3-f]isoindole(9CI)
|
107083-25-0
|
C9H4N2
|
|
Cholestane-3,7,26,27-tetrol
|
107088-80-2
|
|
|
(3R,5S,7R,8S,9S,10R,13R,14S,17S)-17-[(2R)-5,7-dihydroxy-6-methyl-hepta n-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydr o-1H-cyclopenta[a]phenanthrene-3,7-diol
|
107088-81-3
|
C27H48O4
|
|
4-(3-(2-nitro-9-(10H)acridinon-10-yl)propyl)-1-piperazineethanol
|
107088-82-4
|
|
|
8 9-DICYANO-1 4-DIOXA-7 10-DITHIACYCLO-&
|
107089-68-9
|
C10H12N2O2S2
|
|
3-Chloro-4-ethyl-4H-1,2,4-benzothiadiazin-1,1-dioxide
|
107089-77-0
|
C9H9ClN2O2S
|
|
CCAP
|
107090-96-0
|
C42H57N11O11S2
|
|
THIAZOLE ORANGE
|
107091-89-4
|
C26H24N2O3S2
|
|
1-[[[4-Hydroxy-3-[[[2-(tetradecyloxy)phenyl]amino]carbonyl]-1-naphthalenyl]oxy]methyl]-1H-benzotriazole-5-carboxylic acid phenyl ester
|
107091-96-3
|
|
|
4H-1-Benzopyran-4-one,2-(2,6-dihydroxyphenyl)-(9CI)
|
107092-86-4
|
C15H10O4
|
|
N,2,3-Trimethyl-5-nitro-6-quinoxalinamine
|
107095-00-1
|
C11H12N4O2
|
|
5-METHYLAMINO-4-NITRO-2,1,3-BENZOSELENADIAZOLE
|
107095-01-2
|
C7H6N4O2Se
|
|
ethyl 3-(2-ethoxy-2-oxoethoxy)picolinate
|
107095-98-7
|
C12H15NO5
|
|
ethyl 3-hydroxyfuro[3,2-b]pyridine-2-carboxylate
|
107095-99-8
|
C10H9NO4
|
|
Furo[3,2-b]pyridin-3-ol,2,3-dihydro-(9CI)
|
107096-01-5
|
C7H7NO2
|
|
Furo[3,2-b]pyridin-3(2H)-one,2-methyl-(9CI)
|
107096-03-7
|
C8H7NO2
|
|
3-Methylfuro[3,2-b]pyridine-2-carboxylic acid
|
107096-09-3
|
C9H7NO3
|
|
Furo[3,2-b]pyridine,3-methyl-(9CI)
|
107096-11-7
|
C8H7NO
|
|
2-METHYL-6-NITROBENZALDEHYDE
|
107096-52-6
|
C8H7NO3
|
|
2,1-Benzisoxazole-4-carboxaldehyde (9CI)
|
107096-56-0
|
C8H5NO2
|
|
2,1-Benzisoxazole-7-carboxaldehyde (9CI)
|
107096-60-6
|
C8H5NO2
|
|
6-acetoxy-5-chloro-5,6-dihydrothymine
|
107097-08-5
|
C7H9ClN2O4
|
|
2-Propenoic acid sodium salt polymer with 1-ethenyl-2-pyrrolidinone and 2-propen- amide
|
107097-74-5
|
C12H17N2NaO4
|
|
Tosufloxacin tosilate
|
107097-79-0
|
C19H17F3N4O4
|
|
LOXIGLUMIDE
|
107097-80-3
|
C21H30Cl2N2O5
|
|
2,5-Dimethoxyphenylboronic acid
|
107099-99-0
|
C8H11BO4
|
|
5-BROMO-3,4-DIMETHYLBENZENE-1,2-DIAMINE
|
107100-16-3
|
C8H11BrN2
|
|
MONOBROMO-PENTACHLORODIBENZOFURAN
|
107103-81-1
|
|
|
2-METHYL-4,4,4-TRIFLUOROBUTANOL
|
107103-95-7
|
C5H9F3O
|
|
1-BENZYL-4,5-DICHLORO-1H-IMIDAZOLE
|
107108-24-7
|
C10H8Cl2N2
|
|
1,2,3,5,6,7,8,8a-Octahydro-5-(3-hydroxy-3-methyl-4-pentenyl)-1,5,6-trimethyl-1-naphthalenecarboxylic acid
|
107110-07-6
|
|
|
7,8,19,20-Tetrahydro-8-methoxy-15,18-etheno-2,6:9,13-dimetheno-1,14-benzodioxacyclodocosin-11,12,23,24-tetrol
|
107110-23-6
|
C30H28O6
|
|
3,5-[Oxy(1,4-phenylene)ethylene(3-hydroxy-1,2-phenylene)oxy(1,3-phenylene)(2-ethoxyethylene)]catechol
|
107110-24-7
|
|
|
7,8,19,20-Tetrahydro-15,18-etheno-2,6:9,13-dimetheno-1,14-benzodioxacyclodocosin-11,12,19,24-tetrol
|
107110-25-8
|
C28H24O6
|
|
1H-PYRROLE, 2,5-DIMETHYL-1-(1-PHENYLETHYL)-
|
107112-45-8
|
C14H17N
|
|
6,7-Dihydrothieno[3,2-C]-pyridine
|
107112-93-6
|
C7H7NS
|
|
2-Propenal,3-(2-methyl-1H-benzimidazol-1-yl)-(9CI)
|
107113-20-2
|
C11H10N2O
|
|
2-Propenal,3-(2-amino-1H-benzimidazol-1-yl)-(9CI)
|
107113-21-3
|
C10H9N3O
|
|
3-Buten-2-one, 4-(4H-1,2,4-triazol-4-yl)- (9CI)
|
107113-24-6
|
C6H7N3O
|
|
3-Buten-2-one,4-(2-methyl-1H-benzimidazol-1-yl)-(9CI)
|
107113-25-7
|
C12H12N2O
|
|
2H-Pyrido[3,4-e]-1,2-oxazine(9CI)
|
107116-53-0
|
C7H6N2O
|
|
Diisoxazolo[3,4-b:4,5-e]pyrazine (9CI)
|
107116-57-4
|
C6H2N4O2
|
|
parathyroid hormone (3-34)amide
|
107120-62-7
|
|
|
|
phoR protein
|
107121-16-4
|
|
|
(TETRACARBOXYPHTHALOCYANINATO)NICKEL(II)
|
107122-90-7
|
C36H16N8NiO8
|
|
Ethanone, 1-[3,4-bis(methylene)cyclohexyl]- (9CI)
|
107124-02-7
|
C10H14O
|
|
1-Diphenylmethylazetidine
|
107128-00-7
|
C16H17N
|
|
5-(4-FLUORO-PHENYL)-[1,2,4]TRIAZIN-3-YLAMINE
|
107128-47-2
|
C9H7FN4
|
|
S(-)-SCH-23388 NOR METHYL- HCL
|
107128-79-0
|
C16H16ClNO
|
|
2-ethenyl-Pyrrolidine
|
107131-61-3
|
C6H11N
|
|
4-[(S,S)-2,3-EPOXYHEXYLOXY]PHENYL 4-(DECYLOXY)BENZOATE
|
107133-34-6
|
C29H40O5
|
|
Perindopril erbumine
|
107133-36-8
|
C23H43N3O5
|
|
(2S,3R,4R,5R)-2-(6-aminopurin-9-yl)-5-[(hydroxy-methoxy-phosphinothioy l)oxymethyl]oxolane-3,4-diol
|
107133-74-4
|
C11H16N5O6PS
|
|
7-DEAZA-DA CEP
|
107134-59-8
|
C48H53N6O7P
|
|
2-BroMo-3-iodo-1,4-diMethoxybenzene, 97%
|
107135-55-7
|
C8H8BrIO2
|
|
Dipyridamole Di-O-b-D-glucuronide
|
107136-95-8
|
C36H56N8O16
|
|
1H-Phenanthro10,1-bcfuran-8-ol, 2,3,3a,4,5a,6,10b,10c-octahydro-3a,10b-dimethyl-7-(1-methylethyl)-, acetate, (3aR,5aS,10bS,10cR)-
|
107137-02-0
|
C22H30O3
|
|
2,5-Furandione, polymer with 1-butene and ethene, graft
|
107137-84-8
|
C10H14O3
|
|
trienomycin E
|
107140-29-4
|
C35H50N2O7
|
|
PD 124895
|
107140-30-7
|
C32H46O7
|
|
saframycin Ad-1
|
107140-33-0
|
C30H32N4O8
|
|
saframycin Y2b
|
107140-34-1
|
C58H64N10O14
|
|
2-(12-N-dansylaminododecanoyl)-1-myristoylglycerol
|
107141-09-3
|
C41H68N2O7S
|
|
2-(12-(N-(4-azido-2-nitrophenyl))aminododecanoyl)-1-myristoylglycerol
|
107141-10-6
|
|
|
3-Thiophenesulfonamide,2-(hydroxymethyl)-(9CI)
|
107142-08-5
|
C5H7NO3S2
|
|
2-Thiophenesulfonamide,3-cyano-(9CI)
|
107142-12-1
|
C5H4N2O2S2
|
|
4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid
|
107144-30-9
|
C12H14N2O3
|
|
1-CHLORO-2-FORMYL-3-METHYL-BENZO[4,5]IMIDAZO[1,2-A]PYRIDINE-4-CARBONITRILE
|
107145-02-8
|
C14H8ClN3O
|
|
Ethanone, 1-(tetrahydro-2,5,5-trimethyl-2-furanyl)- (9CI)
|
107146-14-5
|
C9H16O2
|
|
CIS-2-(4-METHYLBENZOYL)-1-CYCLOHEXANECARBOXYLIC ACID, 99
|
107147-13-7
|
C15H18O3
|
|
1-(2-METHYLPHENYL)PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE
|
107147-53-5
|
C11H10N2O3
|
|
4-Morpholin-4-yl-benzenethiol
|
107147-60-4
|
C10H13NOS
|
|
P1,P5-DI(ADENOSINE-5') PENTAPHOSPHATE*PE RIODATE OXI
|
107148-01-6
|
C20H25N10O22P5
|
|
T-BUTYLDIETHYLCHLOROSILANE
|
107149-55-3
|
C8H19ClSi
|
|
DIETHYLISOPROPYLSILYL CHLORIDE
|
107149-56-4
|
C7H17ClSi
|
|
6-(2-METHYLPHENYL)-6-OXOHEXANOIC ACID
|
107151-33-7
|
C13H16O3
|
|
6-(2-METHOXYPHENYL)-6-OXOHEXANOIC ACID
|
107151-39-3
|
C13H16O4
|
|
Flavone, 3-ethyl- (6CI)
|
107152-93-2
|
C17H14O2
|
|
Mandelamidine, m-(benzyloxy)- (6CI)
|
107154-19-8
|
C15H16N2O2
|
|
1-BENZOFURAN-2-YL-3-(2-HYDROXY-PHENYL)-PROPENONE
|
107155-10-2
|
C17H12O3
|
|
(3,4-DIMETHOXY-BENZYL)-(3-MORPHOLIN-4-YL-PROPYL)-AMINE
|
107155-56-6
|
C16H26N2O3
|
|
Pyrocincholic acid methyl ester
|
107160-24-7
|
C30H48O3
|
|
|
insulin, 3-(N-phenylacetyl)-
|
107161-05-7
|
|
|
saframycin Y2b-d
|
107163-30-4
|
C60H68N10O14
|
|
1H-Pyrrole-2-carboxylicacid,4-(formylamino)-1-propyl-(9CI)
|
107164-57-8
|
C9H12N2O3
|